Posted by Michael Wonder on 16 Mar 2023
ICER publishes white paper on using comparative effectiveness research to address prescription drug spending in California
16 March 2023 - State policy makers and purchasers in California are uniquely positioned to further integrate comparative effectiveness research into insurance benefit design, formulary development, and price negotiation to ensure all patients have access to effective treatments at a fair price.
The ICER recently published a White Paper, “Applying the Results of Comparative Effectiveness Research to Control Drug Costs: Policy Options for California,” detailing how comparative effectiveness research can be used by policy makers and health insurers in California to address rising drug costs by aligning spending with the degree of benefit a treatment provides.
